Safety of Rapid-Acting Insulin Analogs Versus Regular Human Insulin

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of the Medical Sciences

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MAJ.0b013e3182449ff9PMID 22270400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine

  2011cited by this paper
• A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

  2011cited by this paper
• Immunogenicity of different brands of human insulin and rapid‐acting insulin analogs in insulin‐naïve children with type 1 diabetes

  2011cited by this paper
• Counter‐regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double‐blinded randomized cross‐over study

  2011cited by this paper
• Standards of Medical Care in Diabetes—2011

  2011cited by this paper
• Premeal Injection of Rapid-Acting Insulin Reduces Postprandial Glycemic Excursions in Type 1 Diabetes

  2010cited by this paper
• New injection recommendations for patients with diabetes.

  2010cited by this paper
• Glulisine Versus Human Regular Insulin in Combination With Glargine in Noncritically Ill Hospitalized Patients With Type 2 Diabetes

  2010influential reference
• Severe hypoglycemia and risks of vascular events and death.

  2010cited by this paper
• New injection recommendations for patients with diabetes.

  2010cited by this paper
• Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation

  2010cited by this paper
• Dose-Dependent Delay of the Hypoglycemic Effect of Short-Acting Insulin Analogs in Obese Subjects With Type 2 Diabetes

  2010cited by this paper
• Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus

  2009cited by this paper
• Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

  2009cited by this paper
• Insulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis

  2009cited by this paper
• Managing diabetes in hemodialysis patients: Observations and recommendations

  2009cited by this paper
• Hypoglycemia in Type 1 Diabetic Pregnancy

  2009influential reference
• Effects of Intensive Glucose Lowering in Type 2 Diabetes

  2009cited by this paper
• Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

  2009influential reference
• International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations

  2008cited by this paper
• Insulin Analog Preparations and Their Use in Children and Adolescents with Type 1 Diabetes Mellitus

  2008cited by this paper
• Impaired glucose tolerance is a risk factor for stroke in a Japanese sample--the Funagata study.

  2008cited by this paper
• Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects.

  2008cited by this paper
• Differences in Insulin Action and Secretion, Plasma Lipids and Blood Pressure Levels between Impaired Fasting Glucose and Impaired Glucose Tolerance in Japanese Subjects

  2008cited by this paper
• Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus.

  2008cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes.

  2007cited by this paper
• Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.

  2007cited by this paper
• Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy

  2007cited by this paper
• A review of human and analogue insulin trials.

  2007cited by this paper
• Maternal Metabolic Control and Perinatal Outcome in Women With Gestational Diabetes Mellitus Treated With Lispro or Aspart Insulin

  2007cited by this paper
• Review: Insulin glulisine — the potential for improved glycaemic control

  2007cited by this paper
• Efficacy and safety of insulin glulisine in patients with type 1 diabetes.

  2005cited by this paper
• Insulin analogues.

  2005cited by this paper
• Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes

  2004cited by this paper
• Targeting Plasma Glucose: Preprandial Versus Postprandial

  2004cited by this paper
• Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.

  2003cited by this paper
• Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

  2000cited by this paper
• Pharmacokinetics and pharmacodynamics of insulin Lispro compared with regular insulin in haemodialysis patients with diabetes mellitus.

  1999cited by this paper
• Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

  1999cited by this paper
• Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality

  1999cited by this paper
• Insulin analogues and their potential in the management of diabetes mellitus

  1999cited by this paper
• Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

  1998cited by this paper
• Variability of the metabolic effect of soluble insulin and the rapid-acting insulin analog insulin aspart.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Literature Reviews: Endocrinology

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper

• Regular human insulins versus rapid-acting insulin analogues in children and adolescents with type 1 diabetes: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis

  2025cites this paper
• Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database

  2024cites this paper
• Prandial Insulins: A Person-Centered Choice

  2024cites this paper
• Evaluation of blood glucose changes with regular versus rapid-acting insulin for hyperglycaemia management in the emergency department.

  2023cites this paper
• The Effect of Two Different Insulin Formulations on Postprandial Hyperglycemia after High and Low Glycemic-Index Meal in Type 1 Diabetes

  2022cites this paper
• SYSTEMATIC REVIEW ON MEDICAMENTS USED IN MANAGEMENT OF DIABETES MELLITUS

  2020cites this paper
• Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis

  2020cites this paper
• Physiology of Glycemic Recovery and Stabilization After Hyperinsulinemic Euglycemic Clamp in Healthy Subjects.

  2018cites this paper
• What to do after basal insulin: 3 Tx strategies for type 2 diabetes.

  2015cites this paper
• Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels

  2014cites this paper